Advancing drug discovery via GPU-based deep learning
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Graphics processing units (GPUs) have been used in the computer game and movie industries for several decades. Though initial applications of GPUs were exclusively for creation of computer graphics...
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantum-chemical insights from deep tensor neural networks
Schütt, K. T., Arbabzadah, F., Chmiela, S., Müller, K. R., & Tkatchenko, A. (2017) · Nature Communications · doi:10.1038/ncomms13890 · Cited by 1,445
Deep Neural Nets as a Method for Quantitative Structure–Activity Relationships
Ma, J., Sheridan, R. P., Liaw, A., Dahl, G. E., & Svetnik, V. (2015) · Journal of Chemical Information and Modeling · doi:10.1021/ci500747n · Cited by 1,159 · cited 1×
“This approach is reminiscent of ensemble methods and has generated expectations as demonstrated by Merck ’ s ligand classification machine learning challenge [12].”
MethodDeepTox: toxicity prediction using deep learning
Mayr, A., Klambauer, G., Unterthiner, T., & Hochreiter, S. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00080 · Cited by 1,081 · cited 1×
“DeepTox won the Tox21 toxicity prediction challenge [8].”
BackgroundSchneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910 · cited 1×
“The next 5 – 10 years will bring answers and inspirations [22].”
BackgroundSelf-citationDeep learning for computational chemistry
Goh, G. B., Hodas, N. O., & Vishnu, A. (2017) · Journal of Computational Chemistry · doi:10.1002/jcc.24764 · Cited by 809
Deep Learning in Drug Discovery
Gawehn, E., Hiss, J. A., & Schneider, G. (2016) · Molecular Informatics · doi:10.1002/minf.201501008 · Cited by 723 · cited 1×
“While some successes with ANNs and DNNs for drug discovery are being reported, a fundamental question exists about the topologies of the networks that lead to success or failure [16].”
BackgroundSelf-citationApplication of Generative Autoencoder in De Novo Molecular Design
Blaschke, T., Olivecrona, M., Engkvist, O., Bajorath, J., & Chen, H. (2018) · Molecular Informatics · doi:10.1002/minf.201700123 · Cited by 411
De Novo Design of Bioactive Small Molecules by Artificial Intelligence
Merk, D., Friedrich, L., Grisoni, F., & Schneider, G. (2018) · Molecular Informatics · doi:10.1002/minf.201700153 · Cited by 373
Self-citationSAR Index: Quantifying the Nature of Structure−Activity Relationships
Peltason, L., & Bajorath, J. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0705713 · Cited by 201 · cited 1×
“The requirement that multiple distinct representations of compounds converge on the identification of an activity cliff has already been proposed [17].”
Background
Cited by
Molecular Docking: Shifting Paradigms in Drug Discovery
Pinzi, L., & Rastelli, G. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184331 · Cited by 2,344
Big data and machine learning algorithms for health-care delivery
Ngiam, K. Y., & Khor, I. W. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(19)30149-4 · Cited by 1,424
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Self-citationArtificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Self-citationArtificial Intelligence in Drug Design
Hessler, G., & Baringhaus, K.-H. (2018) · Molecules · doi:10.3390/molecules23102520 · Cited by 373
Metadata
- Authors
- Gawehn, E., Hiss, J. A., Brown, J. B., & Schneider, G.
- Venue
- Expert Opinion on Drug Discovery
- Publisher
- Informa UK Limited
- Published
- 2018-04-18
- Volume
- 13
- Issue
- 7
- Pages
- 579-582
- ISSN
- 1746-0441 (ISSN-L)
- 1746-045X
- OpenAlex
- W2800873928
- Cited by
- 72
- References
- 9
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Advancing drug discovery via GPU-based deep learning. https://app.cochat.ai/papers/10.1080/17460441.2018.1465407
- The paper
- Gawehn, E., Hiss, J. A., Brown, J. B., & Schneider, G. (2018). Advancing drug discovery via GPU-based deep learning. Expert Opinion on Drug Discovery. https://doi.org/10.1080/17460441.2018.1465407
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.